Charting the future of cancer health disparities research: A position statement from the American association for cancer research, the American cancer society, the American society of clinical oncology, & the national cancer institute

Journal of Clinical Oncology

Volumn 35, Issue 26, 2017, Pages 3075-3082

  Polite, Blase N ^a   Adams Campbell, Lucile L ^b   Brawley, Otis W ^c   Bickell, Nina ^d   Carethers, John M ^e   Flowers, Christopher R ^a   Foti, Margaret ^f   Gomez, Scarlett Lin ^g   Griggs, Jennifer J ^e   Lathan, Christopher S ^h   Li, Christopher I ⁱ   Leonard Lichtenfeld, J ^c   Mccaskill Stevens, Worta ^j   Paskett, Electra D ^k  

^a EMORY UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f American Association for Cancer Research   (United States)

^g CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^h DANA FARBER CANCER INSTITUTE   (United States)

ⁱ USA   (United States)

^j NATIONAL CANCER INSTITUTE   (United States)

^k OHIO STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACT; ARTICLE; CANCER CENTER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RESEARCH; CANCER SURVIVOR; CLINICAL TRIAL (TOPIC); FUTUROLOGY; HEALTH CARE POLICY; HEALTH DISPARITY; HUMAN; KNOWLEDGE; MALIGNANT NEOPLASM; MEDICAID; MEDICAL SOCIETY; MULTICENTER STUDY (TOPIC); NATIONAL HEALTH ORGANIZATION; NON PROFIT ORGANIZATION; ONCOLOGY; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; EPIDEMIOLOGY; ETHNOLOGY; FORECASTING; HEALTH CARE DISPARITY; HEALTH SERVICES RESEARCH; NEOPLASM; PRACTICE GUIDELINE; STANDARDS; TRENDS; UNITED STATES;

FORECASTING; HEALTH SERVICES RESEARCH; HEALTHCARE DISPARITIES; HUMANS; MEDICAL ONCOLOGY; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 85029233410     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2017.73.6546     Document Type: Article

References (53)

1. Fontaine SA, Henschke UK, Leffall LD Jr, et al: Comparison of the cancer deaths in the black and white USA population from 1949 to 1967. Med Ann Dist Columbia 41:293-298, 1972.
2. Burbank F, Fraumeni JF Jr: US cancer mortality: Nonwhite predominance. J Natl Cancer Inst 49: 649-659, 1972.
3. National Institutes of Health: Cancer health disparities. https://www.cancer.gov/about-nci/organization/crchd/cancer-health-disparities-fact-sheet#q1.
4. Braveman P.A, Kumanyika S, Fielding J, et al: Health disparities and health equity: The issue is justice. Am J Public Health 101:S149-S155, 2011 (suppl).
5. Howlader N, Noone AM, Krapcho M, et al: (eds). SEER Cancer Statistics Review, 1975-2013. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975-2013/.
6. National Cancer Institute, Surveillance, Epidemiology, and End Results Program: Cancer of the Female Breast (Invasive). https://seer.cancer.gov/csr/1975-2014/results-merged/sect-04-breast.pdf.
7. Shariff-Marco S, Yang J, John EM, et al: Intersection of race/ethnicity and socioeconomic status in mortality after breast cancer. J Community Health 40:1287-1299, 2015.
8. Williams DR, Kontos EZ, Viswanath K, et al: Integrating multiple social statuses in health disparities research: The case of lung cancer. Health Serv Res 47:1255-1277, 2012.
9. Warnecke RB, Oh A, Breen N, et al: Approaching health disparities from a population perspective: The National Institutes of Health Centers for Population Health and Health Disparities. Am J Public Health 98:1608-1615, 2008.
10. Lynch SM, Rebbeck TR: Bridging the gap between biologic, individual, and macroenvironmental factors in cancer: A multilevel approach. Cancer Epidemiol Biomarkers Prev 22:485-495, 2013.
11. Gomez SL, Shariff-Marco S, DeRouen M, et al: The impact of neighborhood social and built environment factors across the cancer continuum: Current research, methodological considerations, and future directions. Cancer 121:2314-2330, 2015.
12. Institute of Medicine: The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. Washington, DC, The National Academies Press, 2001.
13. Lam TK, Spitz M, Schully SD, et al: Drivers of translational cancer epidemiology in the 21st century: Needs and opportunities. Cancer Epidemiol Biomarkers Prev 22:181-188, 2013.
14. Palmer JR, Ambrosone CB, Olshan AF: A collaborative study of the etiology of breast cancer subtypes in African American women: The AMBER consortium. Cancer Causes Control 25:309-319, 2014.
15. Bandera EV, Chandran U, Hong CC, et al: Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER Consortium. Breast Cancer Res Treat 150:655-666, 2015.
16. Bethea TN, Rosenberg L, Hong CC, et al: A case-control analysis of oral contraceptive use and breast cancer subtypes in the African American Breast Cancer Epidemiology and Risk Consortium. Breast Cancer Res 17:22, 2015.
17. Haddad SA, Lunetta KL, Ruiz-Narvaez EA, et al: Hormone-related pathways and risk of breast cancer subtypes in African American women. Breast Cancer Res Treat 154:145-154, 2015.
18. Han Y, Hazelett DJ, Wiklund F, et al: Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions. Hum Mol Genet 24:5603-5618, 2015.
19. Berndt SI, Wang Z, Yeager M, et al: Two susceptibility loci identified for prostate cancer aggressiveness. Nat Commun 6:6889, 2015.
20. O'Keefe SJ, Li JV, Lahti L, et al: Fat, fibre, and cancer risk in African Americans and rural Africans. Nat Commun 6:6342, 2015.
21. Grubbs SS, Polite BN, Carney J Jr, et al: Eliminating racial disparities in colorectal cancer in the real world: It took a village. J Clin Oncol 31: 1928-1930, 2013.
22. Kupfer SS, Carr RM, Carethers JM: Reducing colorectal cancer risk among African Americans. Gastroenterology 149:1302-1304, 2015.
23. Carethers JM: Screening for colorectal cancer in African Americans: Determinants and rationale for an earlier age to commence screening. Dig Dis Sci 60:711-721, 2015.
24. Hunt BR, Whitman S, Hurlbert MS: Increasing black-white disparities in breast cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol 38:118-123, 2014.
25. Bickell NA, Shastri K, Fei K, et al: A tracking and feedback registry to reduce racial disparities in breast cancer care. J Natl Cancer Inst 100: 1717-1723, 2008.
26. Rhoads KF, Patel MI, Ma Y, et al: How do integrated health care systems address racial and ethnic disparities in colon cancer? J Clin Oncol 33: 854-860, 2015.
27. National Academies of Sciences, Engineering, and Medicine: Systems Practices for the Care of Socially At-Risk Populations. Washington, DC, The National Academies Press, 2016.
28. Carethers JM, Murali B, Yang B, et al: Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer. PLoS One 9: E100461, 2014.
29. Guda K, Veigl ML, Varadan V, et al: Novel recurrently mutated genes in African American colon cancers. Proc Natl Acad Sci USA 112:1149-1154, 2015.
30. American College of Surgeons: Rapid Quality Reporting System (RQRS). https://www.facs.org/quality-programs/cancer/ncdb/qualitytools/rqrs.
31. Maitland ML, DiRienzo A, Ratain MJ: Interpreting disparate responses to cancer therapy: The role of human population genetics. J Clin Oncol 24: 2151-2157, 2006.
32. Collins FS, Varmus H: A new initiative on precision medicine. N Engl J Med 372:793-795, 2015.
33. Collins FS, Hamburg MA: First FDA authorization for next-generation sequencer. N Engl J Med 369:2369-2371, 2013.
34. Feero WG, Guttmacher AE, Collins FS: Genomic medicine: An updated primer. N Engl J Med 362:2001-2011, 2010.
35. Guttmacher AE, Collins FS: Welcome to the genomic era. N Engl J Med 349:996-998, 2003.
36. Hamburg MA, Collins FS: The path to personalized medicine. N Engl J Med 363:301-304, 2010.
37. Hudson KL, Holohan MK, Collins FS: Keeping pace with the times: The Genetic Information Nondiscrimination Act of 2008. N Engl J Med 358: 2661-2663, 2008.
38. Collins FS: Shattuck lecture: Medical and societal consequences of the Human Genome Project. N Engl J Med 341:28-37, 1999.
39. Barkin S, Schlundt D, Smith P: Communityengaged research perspectives: Then and now. Acad Pediatr 13:93-97, 2013.
40. Institute of Medicine: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC, National Academies Press, 2001.
41. Institute of Medicine: Unequal Treatment. Washington, DC, The National Academies Press, 2003.
42. Tapp H, White L, Steuerwald M, et al: Use of community-based participatory research in primary care to improve health care outcomes and disparities in care. J Comp Eff Res 2:405-419, 2013.
43. Stange KC, Breslau ES, Dietrich AJ, et al: State-of-The-Art and future directions in multilevel interventions across the cancer control continuum. J Natl Cancer Inst Monogr 2012:20-31, 2012.
44. Colditz GA, Wolin KY, Gehlert S: Applying what we know to accelerate cancer prevention. Sci Transl Med 4:127rv4, 2012.
45. Institute of Medicine: The unequal burden of cancer: An assessment of NIH research and programs for ethnic minorities and the medically underserved. Washington, DC, The National Academies Press, 1999.
46. National Science Foundation: Division of Science Resources Statistics: Women, minorities, and persons with disabilities in science and engineering: 2011. Special Report NSF 11-309. Arlington, VA, National Science Foundation, 2011. http://www.nsf.gov/statistics/wmpd/.
47. Institute of Medicine. A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. The National Academies Press, Washington, DC. 2010.
48. Adams-Campbell LL, Ahaghotu C, Gaskins M, et al: Enrollment of African Americans onto clinical treatment trials: Study design barriers. J Clin Oncol 22:730-734, 2004.
49. Ford JG, Howerton MW, Lai GY, et al: Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review. Cancer 112: 228-242, 2008.
50. Arnold KB, Hermos JA, Anderson KB, et al: Retention of black and white participants in the selenium and vitamin E cancer prevention trial (SWOGcoordinated intergroup study S0000). Cancer Epidemiol Biomarkers Prev 23:2895-2905, 2014.
51. Greiner KA, Friedman DB, Adams SA, et al: Effective recruitment strategies and communitybased participatory research: Community networks program centers' recruitment in cancer prevention studies. Cancer Epidemiol Biomarkers Prev 23: 416-423, 2014.
52. Fouad MN, Johnson RE, Nagy MC, et al: Adherence and retention in clinical trials: A communitybased approach. Cancer 120:1106-1112, 2014 (suppl).
53. Cancer and Aging Research Group. http://www.mycarg.org.